Teva’s Effexor Generic Launches Following ANDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva began shipping the generic of Wyeth's antidepressant Aug. 4.
You may also be interested in...
Effexor XR Labeling Update Advises Of Increased Risk Of Fatal Outcomes Versus SSRIs
Wyeth issues “Dear Healthcare Provider” letter advising that venlafaxine overdose may be associated with increased risk of fatal outcomes.
Effexor XR Labeling Update Advises Of Increased Risk Of Fatal Outcomes Versus SSRIs
Wyeth issues “Dear Healthcare Provider” letter advising that venlafaxine overdose may be associated with increased risk of fatal outcomes.
J&J Lawsuit Claims Wyeth’s Effexor XR Infringes Patent
Johnson & Johnson subsidiary Alza files patent infringement suit against Wyeth.